Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) (CHGCY) Live Share Price, Invest From India

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock Performance

as on October 31, 2026 at 6:58 am IST

Day's Low
Day's High
$21.30
Day's Price Range
$21.86
$21.70
1.84%
Downside
0.74%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$21.70
100.00%
Downside
-100.00%
Upside

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share price movements today

Previous Close: $21.15
Open: $21.30
Volume: 147.5K
Market Cap: $69.0B
Dividend Yield: 0.03%
Day's Low - High: $21.30 - $21.86

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Historical Returns

1 Month Return: + 8.07 %
3 Month Return: -4.51 %
1 Year Return: -4.21 %
3 Year Return: + 45.56 %
5 Year Return: 0 %

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock Fundamentals & Key Indicators

Check Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.0B

EPS (TTM)

Dividend Yield

0.03%

PE Ratio (TTM)

21.63

Industry PE ratio

9.58

PEG Ratio

1.77

Return On Equity TTM

25.32%

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Chugai Pharmaceutical Ltd Unsponsored ADR (Japan)	NA	$69.0B	NA	21.63	35.61%	0.03%
Eli Lilly & Co	StrongBuy	$1.2T	439.21%	43.12	83.40%	0.52%
AbbVie	StrongBuy	$505.4B	153.59%	80.67	71.48%	2.42%
Johnson & Johnson	Buy	$652.5B	68.96%	41.09	68.81%	1.95%
Merck & Company	Buy	$347.7B	66.19%	112.00	75.38%	2.41%

See all

Stock Returns calculator for Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock including INR - Dollar returns

The Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) investment value today

Current value as on today

₹1,05,123

Returns

₹5,123

(+5.12%)

Returns from Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock

-₹1,721 (-1.72%)

Dollar Impact

₹6,844 (+6.84%)

Indian Investors' Interest in Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock

Search interest for Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 1, 2026 to October 31, 2026

Change:-18% versus previous 30 day period

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Revenue	1,999	2,204	1,960	1,934	290,004	338,985	401,477	327,657	346,081	404,743
Gross Profit	1,442	1,616	1,348	1,345	201,936	236,997	298,034	233,163	241,099	285,651
Operating Income	158,321	160,407	121,061	136,651	127,683	182,270	172,469	165,657	162,681	202,947
EBITDA	166,045	160,806	153,866	137,050	144,831	178,997	207,611	174,619	162,681	193,436
Interest Expense	-	-	-	-	57	59	930	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	158,801	158,837	125,507	135,829	136,001	158,793	172,972	163,139	171,248	204,686
Income Tax Expense	46,941	49,341	33,948	38,595	38,846	45,640	48,653	45,601	53,386	61,131
Net Income	707	764	594	652	97,155	113,152	147,511	117,538	117,862	143,553
Net Profit Margin	35.41%	34.69%	30.31%	33.71%	33.50%	33.38%	36.74%	35.87%	34.06%	35.47%

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	4,239	4,728	5,163	6,285	7,582	8,783	9,331	7,726	7,597	1,318,925
Gross Profit	2,101	2,478	2,822	3,848	4,947	5,812	5,804	4,853	5,394	937,603
Operating Income	76,884	98,934	124,323	210,597	301,230	421,897	533,309	439,174	542,002	618,804
EBITDA	93,253	115,268	121,560	234,419	328,726	450,301	564,743	476,465	575,555	661,976
Interest Expense	86	110	111	125	62	48	61	27	1,027	1,075
Depreciation	-	16,334	-	-	-	-	-	-	-	-
Income Before Tax	74,448	97,031	121,449	207,893	298,188	419,385	531,166	443,821	543,034	626,788
Income Tax Expense	20,076	23,490	28,370	50,333	83,455	116,390	156,737	118,349	155,717	171,734
Net Income	461	643	823	1,443	2,069	2,662	2,773	2,262	2,513	455,052
Net Profit Margin	10.90%	13.61%	15.95%	22.96%	27.29%	30.31%	29.72%	29.29%	33.09%	34.50%

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Quarterly Cash Flow

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Net Income	109,496	91,559	97,234	97,155	113,152	130,728	117,538	117,862	214,563
Operating Cash Flow	123,643	152,394	66,677	821	75,218	135,085	125,670	130,216	57,223
Investing Cash Flow	-37,572	-16,903	-86,886	-334	93,511	-171,788	114,351	-155,117	49,628
Financing Cash Flow	-69,506	-2,031	-95,378	-33	-212,787	654	-248,930	-4,782	-110,915
Change in Cash	403,958	-403,958	423,419	609	-52,633	-57,870	-15,065	-36,328	-8,134

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	124,776	151,857	249,500	340,228	470,367	575,875	325,472	589,546	455,052
Operating Cash Flow	107,623	119,074	206,641	205,035	279,626	244,112	409,925	447,600	408,331
Investing Cash Flow	-36,718	-74,060	-81,741	-98,312	-118,927	-145,994	-37,290	-227,365	-214,805
Financing Cash Flow	-29,563	-35,014	-66,872	-99,497	-107,408	-145,641	-139,331	-141,006	-322,362
Change in Cash	43,706	7,786	57,081	8,392	55,420	-45,584	236,505	81,528	-112,250

Insights on Chugai Pharmaceutical Ltd Unsponsored ADR (Japan)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Chugai Pharmaceutical Ltd's Unsponsored ADR has shown a positive profit trend over the last three quarters. The net profit increased from $117.53 billion to $143.55 billion. This reflects an average growth of 9.1% in net profit per quarter.
POSITIVE IMPACT
Revenue Rich
Chugai Pharmaceutical Ltd's revenue has shown consistent growth over the last three quarters. It increased from $327.65 billion to $404.74 billion, reflecting an average growth of 9.9% per quarter.
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, CHGCY has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Merck & Co., Inc. has given 70.2% return, outperforming this stock by 77.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CHGCY stock has moved down by -1.8%

About Chugai Pharmaceutical Ltd Unsponsored ADR (Japan)

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept, an immunosuppressant; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi, a spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, an anti VEGF/anti Ang-2 bispecific antibody. The company has a collaboration with Phylo, Inc. to deploy an agentic AI platform for biomedical research across its drug discovery workflow. The company was formerly known as Chugai Shinyaku Shokai and changed its name to Chugai Pharmaceutical Co., Ltd. in January 1943. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding AG.

Organisation	Chugai Pharmaceutical Ltd Unsponsored ADR (Japan)
Headquarters	Nihonbashi Mitsui Tower, Chuo, Japan, 103-8324
Industry	Drug Manufacturers - General
CEO	Dr. Osamu Okuda

Key Management of Chugai Pharmaceutical Ltd Unsponsored ADR (Japan)

Name	Title
Dr. Osamu Okuda	President, CEO & Chairman
Toshiya Sasai	Executive of Investor Relations Group & Corporate Communications Department
Junichi Takano	Head of Marketing & Sales Division
Mr. Yoshiyuki Yano	Executive Vice President
Mr. Iwaaki Taniguchi	Senior Executive Officer, CFO, Head of Finance & Director
Mr. Shinji Hidaka	Executive Vice President
Mr. Tetsuya Yamaguchi	Executive Vice President
Mr. Kosuke Iijima	Head of PHC Solution Department
Dr. Tomoyuki Igawa Ph.D.	VP & Head of Research Division
Dr. Kaori Ouchi	Executive Vice President

FAQs

What is Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share price today?

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share price today is $21.70 as on October 31, 2026 at 1:28 am IST at the close of the market. Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share today touched a day high of $21.86 and a low of $21.30.

What is the 52 week high and 52 week low for Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share?

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) stock price today i.e. October 31, 2026 at 1:28 am IST is closed at $21.70,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Chugai Pharmaceutical Ltd Unsponsored ADR (Japan)'s market capitalisation today?

Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) market capitalisation is $0.07T as on October 31, 2026 at 1:28 am IST.

How to invest in Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock (CHGCY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) Stock (CHGCY) from India?

Indian investors can start investing in Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) (CHGCY) shares with as little as ₹94.94999694824219 or $1 (as of October 31, 2026 at 8:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) stock (as per the Rupee-Dollar exchange rate as on October 31, 2026 at 8:37 pm IST). Based on Chugai Pharmaceutical Ltd Unsponsored ADR (Japan) share’s latest price of $21.70 as on October 31, 2026 at 1:28 am IST, you will get 0.4608 shares of Chugai Pharmaceutical Ltd Unsponsored ADR (Japan). Learn more about fractional shares .